The Pfiz­er pa­pers; Bio­gen lay­offs be­gin; Ab­b­Vie inks a buy­out; GSK makes Slaoui pay; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We are sad­dened this week to say good­bye to our man­ag­ing ed­i­tor, Kyle Blanken­ship, as he be­gins a new chap­ter in his ca­reer. But we are equal­ly grate­ful for the time to­geth­er and ex­cit­ed about the team he’s helped shape.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.